Bescheiden Pharmaceuticals Private Limited
About Bescheiden Pharmaceuticals Private Limited
Data last updated:
Bescheiden Pharmaceuticals Private Limited is a private limited company based in Gmc, Assam, India. It was incorporated on 28 November 2023.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U46497AS2023PTC025584.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Nayanjyoti Kalita and Srimanta Das.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gmc, Assam.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.04 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.87 Lakh (net margin 6.7%) and EBITDA of ₹1.98 Lakh (EBITDA margin 7.1%).
Company details
Contact details
Bescheiden Pharmaceuticals Private Limited's registered office is in Gmc, Assam.
- Registered AddressC/O. Nava Kumar Das, H No – 10 Vivekananda Path, Gmc, Assam, India – 781034
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bescheiden Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bescheiden Pharmaceuticals Private Limited, buy the company report.
Financials of Bescheiden Pharmaceuticals Private Limited
FY 2025 filings availableBescheiden Pharmaceuticals Private Limited reported revenue of ₹28.04 Lakh (up 840% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 840% in the latest year. EBITDA rose 163% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹1.98 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹1.87 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 7.1% | |
| Net Profit Margin | 6.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Bescheiden Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bescheiden Pharmaceuticals Private Limited
Bescheiden Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nayanjyoti Kalita | Director | 28 Nov 2023 | 2 Years 11 Months | Current |
| Srimanta Das | Director | 28 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Bescheiden Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eshar Pharmaceuticals Private Limited | ₹28.21 Lakh (FY 2023) | 4.0% | Ahmedabad, Gujarat, India | |||
| Vvio Pharmaceuticals Private Limited | ₹28.04 Lakh (FY 2023) | Bangalore, Karnataka, India | ||||
| Bescheiden Pharmaceuticals Private Limitedthis company | ₹28.04 Lakh (FY 2025) | ₹1.87 Lakh | 6.7% | 840.0% | Gmc, Assam, India | |
| Tangible Pharmaceuticals Private Limited | ₹27.89 Lakh (FY 2025) | -30.0% | Mirzapur, Uttar Pradesh, India | |||
| Neptune Pharmaceuticals Private Limited | ₹27.79 Lakh (FY 2025) | 28.0% | Srinagar, Jammu and Kashmir, India |
To see the full peer comparison of Bescheiden Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bescheiden Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bescheiden Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bescheiden Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bescheiden Pharmaceuticals Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Juri Talukdar ceased to be Director on 01 Dec 2025.
Frequently asked questions
Bescheiden Pharmaceuticals is an active private limited company based in Gmc, Assam, India. It was incorporated on 28 November 2023 (3+ years old) and is registered under CIN U46497AS2023PTC025584.
Bescheiden Pharmaceuticals has 2 current directors:
- Nayanjyoti Kalita - Director
- Srimanta Das - Director
The latest financial statements of Bescheiden Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Bescheiden Pharmaceuticals is U46497AS2023PTC025584. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bescheiden Pharmaceuticals was incorporated on 28 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Bescheiden Pharmaceuticals by revenue are Eshar Pharmaceuticals Private Limited, Vvio Pharmaceuticals Private Limited, Tangible Pharmaceuticals Private Limited, Neptune Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Juri Talukdar ceased to be Director on 01 Dec 2025. Juri Talukdar was appointed as Director on 28 Sep 2024. Nayanjyoti Kalita was appointed as Director on 28 Nov 2023. Bescheiden Pharmaceuticals has 4 board changes on record in total.
The registered office of Bescheiden Pharmaceuticals is at CO. Nava Kumar Das, H No – 10 Vivekananda Path, Gmc, Assam, India – 781034.
Bescheiden Pharmaceuticals can be reached at its registered office: CO. Nava Kumar Das, H No – 10 Vivekananda Path, Gmc, Assam, India – 781034.
Bescheiden Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Guwahati.